Pharma IP Circle

A niche blog dedicated to "Drug Patent Litigation Decisions" across major jurisdictions

Friday, June 29, 2018

Zolmitriptan – USA

›
On Jun 28, 2018, the Federal Circuit affirmed district court’s decision that formulation patents of drug, ZOMIG ® are valid. Lannett...
Wednesday, June 27, 2018

Tenofovir + Emtricitabine - Switzerland

›
On June 11, 2018, the Federal Supreme Court dismissed Mepha’s appeal & affirmed Validity of Gilead’s Swiss TRUVADA® SPC. By sub...
Monday, June 25, 2018

Pemetrexed - USA

›
On Jun 22, 2018, U.S. District Court for the Southern District of Indiana ruled in favor of Lilly finding that Dr. Reddy’s alternate salt...
Saturday, June 23, 2018

Zoledronic acid – USA

›
PGR decision (Jun. 22, 2018): AIA Review Institution Date Petitioner Patent No. Final Writte...
Friday, June 22, 2018

Glycerol Phenylbutyrate – USA

›
On Jun 18, 2018, the Federal Circuit in one-liner order affirmed PTAB’s decision that method of treatment patent of drug, RAVICTI® is va...
Friday, June 15, 2018

Rituximab - Australia

›
On Jun 12, 2018, Federal Court of Australia granted Roche a preliminary injunction against Sandoz’s biosimilar on the basis prima facie c...

Valsartan & Amlodipine - France

›
On Jun 07, 2018, the tribunal de grande instance of Paris issued a preliminary injunction against Teva’s generic of anti-hypertensive dru...
Thursday, June 14, 2018

Rosuvastatin - Netherlands

›
On Jun 08, 2018, the Supreme Court of Netherlands upheld the decision of Court of Appeal & held that the AstraZeneca’s Crestor® paten...
Tuesday, June 12, 2018

Bendmustine - USA

›
On Jun 11, 2018, Eagle Pharmaceuticals, Inc. announced that the U.S. District Court for the District of Columbia (the Court) has issued a...

Prevnar 13 - USA

›
IPR decision (Jun. 08, 2018): AIA Review Institution Date Petitioner Patent No. Final Written Decision ...
‹
›
Home
View web version

Mahendraa

Mahendraa
View my complete profile
Powered by Blogger.